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Role of the Peripheral Vasculature in
Changes in Venous Return Caused by
Isoproterenol, Norepinephrine, and
Methoxamine in Anesthetized Dogs
YUTAKA IMAI, KEISUKE SATOH, AND NORIO TAIRA
SUMMARY We studied effects on venous return of a- and /8-adrenergic agonists in anesthetized dogs.
Blood from the superior and inferior venae cavae (venous return) was drained at the level of the
tricuspid valve into a reservoir, from which blood was pumped into the right atrium at a constant rate.
Isoproterenol infused into the ascending aorta or the right atrium increased the venous return and
heart rate and decreased systemic blood pressure. The increase in venous return produced by isopro-
terenol given into the right atrium was not significantly different from that produced by isoproterenol
administered into the ascending aorta, although the increase in heart rate was more marked with the
latter route of administration. Norepinephrine infused into the ascending aorta increased the systemic
blood pressure, venous return, and heart rate. Methoxamine infused into the ascending aorta increased
the systemic blood pressure and decreased the venous return but produced no change in heart rate.
Isoproterenol increased the venous return even when the sinoaortic baroreceptor reflex was eliminated.
Propranolol abolished the increase in venous return caused by isoproterenol and reversed the increase
in venous return caused by norepinephrine. The results suggest that a decrease in venous resistance
mediated through a j8-adrenergic mechanism is important in increasing venous return, whereas an
increase in venous resistance mediated through an a-adrenergic mechanism is responsible for a
decrease in venous return.
REFLEX augmentation of sympathetic tone by
carotid sinus hypotension1"3 or stimulation of the
lumbar sympathetic nerves4 causes an increase in
venous return which has been attributed to an
increase in venous tone.1"3 Intravenous injection of
epinephrine or norepinephrine also increases ve-
nous return,5"7 and this also has been attributed to
an increase in venous tone or to a decrease in
venous capacitance.6'7 Kaiser et al.6 observed, in
dogs on cardiopulmonary bypass, that isoprote-
renol, epinephrine, and phenylephrine all increase
venous return. They interpreted the increased ve-
nous return induced by epinephrine and phenyleph-
rine as being due to venoconstriction mediated by
a-adrenergic stimulation and the increase in venous
return caused by isoproterenol as also due to ve-
noconstriction mediated by venous /?-adrenergic re-
ceptors. Green8 also observed that isoproterenol
increased venous return in dogs on right heart by-
pass. However, as opposed to the explanation given
by Kaiser et al.,6 Green suggested that the increase
in venous return caused by isoproterenol resulted
in large part from dilation of venous resistance
vessels.
In view of the present state of our knowledge of
vascular mechanisms and adrenergic receptors in-
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volved in changes in venous return induced by
sympathomimetic amines, we designed the present
experiments. For this purpose, we used the open-
loop method in which the cardiac input was held
constant, and examined the effects on the cardio-
hemodynamics of three sympathomimetic amines,
isoproterenol which is a relatively pure /?-adrenergic
stimulant,9 methoxamine, a relatively pure a-adre-
nergic stimulant,9 and norepinephrine, which has
both a- and /8-adrenergic effects.9 We also investi-
gated how the actions of these three sympathomi-
metic amines would be modified by elimination of
the baroceptor reflex, by /8-adrenergic receptor
blockade by propranolol, or by reduction of vascular
tone by a vasodilator drug, SK&F 24260.10
Methods
Experiments were performed on 40 young,
healthy mongrel dogs of both sexes, weighing 10-15
kg (mean ± SE = 12.3 ± 0.3). The animals initially
were anesthetized with sodium pentobarbital (30
mg/kg, iv) and then received hourly doses of 4-6
mg/kg, sc. Positive pressure ventilation was initi-
ated at 18 breaths/min with a tidal volume of 20
ml/kg (Harvard Apparatus, model 607) and a mid-
sternal incision was made. The vagus and phrenic
nerves were cut bilaterally. The azygos vein was
ligated and the heart suspended in pericardial cra-
dle. A schema of intra- and extracorporeal circula-
tion is shown in Figure 1. After the dog had been
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FIGURE 1 Schematic representation of the experimen-
tal system. AO = aorta, IVC = inferior vena cava, SVC
= superior vena cava, PA = pulmonary artery, PV =
pulmonary vein, SBP = systemic blood pressure, SOP
= systemic output, CIP = cardiac input, VR = venous
return, RV = reservoir volume, RAP = right atrial
pressure, HR = heart rate, PT = pressure transducer,
FP = probe of electromagnetic flow meter, PP = peri-
staltic pump, A and B = points of drug infusion or
injection, 1 = first (relay) reservoir, 2 = second reservoir.
Arrows indicate direction of blood flow.
given sodium heparin (500 U/kg, iv), glass cannulas
were inserted into the superior and inferior venae
cavae, and blood from these cannulas was led
through Y-tubing to a relay reservoir of about 20
ml. Thus the venous return provided the outflow
from the Y-tubing. The level of the relay reservoir
was maintained at the level of the tricuspid valve.
The blood from the relay reservoir was drained into
another 1.5-liter reservoir (second reservoir) sur-
rounded by a water jacket maintained at 39°C. The
second reservoir had been primed with about 1 liter
of fresh whole blood from donor dogs. The blood in
the second reservoir was pumped into the cannu-
lated right atrium by a peristaltic pump (Harvard
Apparatus, model 1215). The cardiac input was
adjusted initially to maintain the systemic blood
pressure in a physiological range and was kept
constant throughout the experiment. Thus, a
change in blood volume in the second reservoir
reflected a total blood shift from the experimental
dog, and was measured as a change in hydrostatic
pressure of the second reservoir by a pressure trans-
ducer (Nihon Kohden, LPU-0.1). A cannulating
probe of an electromagnetic flow meter (Nihon
Kohden, MF-46) was placed between the Y-tubing
and the relay reservoir to measure the venous re-
turn. The cardiac input was monitored by another
flow probe placed between the pump and the right
atrium. In experiments of series 1-4, the systemic
output was monitored by a noncannulating probe
fit for the ascending aorta. However, for accurate
measurements of the systemic output, in series 5
experiments, two cannulating flow probes were
used; one was placed in the descending thoracic
aorta and the other in the brachiocephalic artery.
Blood flow through the brachiocephalic artery was
secured in such a way that, after ligation of the left
subclavian artery, blood from the proximal stump
of the cut subclavian artery was led to the distal
stump of the cut brachiocephalic artery through
the flow probe. The phasic systemic blood pressure
was measured in the left femoral artery by a pres-
sure transducer (Nihon Kohden, MPU-0.5). The
mean right atrial pressure was measured by another
pressure transducer (Nihon Kohden, LPU-0.1). The
zero base line reference for the right atrial pressure
was set equal to the hydrostatic level of the tricus-
pid valve. The heart rate was measured by a car-
diotachometer (San-ei, Biophysiograph type 2130)
which was triggered by the R waves of a lead II
ECG. Recordings were made on charts by two rec-
tilinear polygraphs (San-ei, Rectiholy 8S and Rec-
tiholiz 8S). Not all of the seven cardiohemodynamic
parameters were successfully measured in each dog.
Tyrode's solution was transfused at rates of 40-60
ml/hr to maintain a stable hemodynamic state by
preventing the negative balance of body fluid during
the experiment. The blood oozing from the wound
into the thoracic cavity was pumped into the second
reservoir by a peristaltic pump (Harvard Appara-
tus, model 607).
In series 3 experiments, bilateral carotid sinus
denervation was performed as follows. The upper
cervical region was incised in the midline, and the
internal, external, and common carotid arteries
were exposed on both sides. The carotid sinus
nerves were carefully dissected free on both sides
and severed surgically, and a minute amount of
cresol solution was applied to the carotid sinus to
ensure complete destruction of the nerves. Bilateral
denervation of the carotid sinuses was judged to be
virtually complete when elevation of the systemic
blood pressure on bilateral occlusion of the common
carotid arteries was nearly abolished. The aortic
baroceptor reflex was eliminated by the bilateral
vagotomy.
The drugs used included Z-isoproterenol hy-
drochloride (Nikken Kagaku), Z-norepineph-
rine (Fluka), rf/-methoxamine hydrochloride (Ni-
honshinyaku), dZ-propranolol hydrochloride (ICI),
and l,4-dihydro-2,6-dimethyl-4-(2-trifluoromethyl-
phenyl)-3,5-pyridinedicarboxylic acid diethyl ester
(SK&F 24260, Smith Kline & French Laboratories).
Norepinephrine was dissolved in 0.01 N HC1. SK&F
24260 was dissolved in Tween 80 (Wako) at a con-
centration of 20 mg/ml. All other drugs were dis-
solved in 0.9% saline. All drug solutions were diluted
with 0.9% saline to the desired concentrations. So-
lutions of the three sympathomimetic amines were
infused at a rate of 1 ml/min for 3 minutes into the
ascending aorta to minimize their cardiac effects.
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TABLE 1 Control Values of Cardiohemodynamic Parameters
Series
no.
1
2
3
4
5
Total
No. of
experi-
ments
21
5
5
5
8
40
SBP
(mm Hg)
134 ± 5
113 ±9
117 + 5
128 ± 12
106 ±8
124 ±4
DBP
(mmHg)
62 ±5
64±9
53 + 7
65 ±9
78 ± 7
67 ±3
CIP
(ml/kg per min)
52.7 + 1.3
59.2 ± 3.3
56.4 ± 3.7
55.7 ± 1.0
62.1 ± 4.3
55.7 + 1.4
HR
(beats/min)
180 ±6
192 ± 10
191 ±9
196 ± 10
205 + 7
188 ±4
SBP and DBP: systolic and diastolic blood pressure; CIP: cardiac input; HR: heart rate. Some dogs were
subjected to two series of experiments. Values are means ± SE.
However, in series 1 experiments, isoproterenol so-
lutions also were infused at a rate of 1 ml/min into
the right atrium. Other drug solutions in a volume
of 1 ml (for 10 seconds) were injected into the
ascending aorta. Doses of drugs, except for norepi-
nephrine and SK&F 24260, refer to their salts. We
gave one to three of the three sympathomimetic
amines to each dog; subsequent doses were given
when the effect of the previous dose disappeared
nearly completely. The order of drug administration
was randomized.
Values of cardiohemodynamic responses used for
construction of dose-response curves for the three
sympathomimetic amines are those obtained at 3
minutes after start of drug infusion. Values are
expressed as mean ± SE of the mean. Statistical
significance of the difference between mean values
was analyzed by Student's f-test.
Results
Table 1 shows the control values of four cardio-
hemodynamic parameters in five series of experi-
ments. Some dogs were subjected to two series of
experiments, and most dogs received two and, a few
dogs, three of the three sympathomimetic amines.
Series 1: Effects ofThree Sympathomimetic
Amines on Cardiohemodynamics
Effects of Isoproterenol
Isoproterenol was infused at rates of 0.03, 0.1, and
0.3 /tg/kg per min for 3 minutes into either the right
atrium or the ascending aorta in 11 dogs. Results of
a typical experiment are depicted in Figure 2, and
summarized results are presented in Figure 3. When
infused into the ascending aorta, isoproterenol pro-
duced decreases in systolic and diastolic blood pres-
sure and increases in reservoir volume and heart
rate in a dose-dependent manner, but no significant
change in right atrial pressure. When isoproterenol
was infused into the right atrium, the diastolic blood
pressure and the right atrial pressure were de-
creased, and the reservoir volume and the heart
rate were increased in a dose-dependent manner,
whereas the systolic blood pressure remained vir-
tually unchanged. The increase in heart rate pro-
duced by the three doses of isoproterenol given into
the right atrium clearly was greater than that
caused by corresponding doses of isoproterenol ad-
ministered into the ascending aorta (Fig. 3, P < 0.01
in all doses). However, the increase in reservoir
volume produced by the three doses of isoprote-
renol infused into the right atrium was not signifi-
cantly different from that produced by correspond-
ing doses of isoproterenol infused into the ascending
aorta (Fig. 3, P > 0.8).
Effects of Norepinephrine
Norepinephrine was infused at rates of 0.3,1, and
3 fig/kg per min for 3 minutes into the ascending
aorta in 13 dogs. In 12 of the 13 dogs, norepinephrine
caused dose-dependent increases in systolic and
diastolic blood pressure and in reservoir volume
(Fig. 4). The right atrial pressure decreased and the
heart rate increased only with higher doses of nor-
epinephrine (1 and 3 jug/kg per min for 3 minutes)
(Fig. 4). However, in one of the 13 dogs, the reser-
voir volume decreased at all doses of norepineph-
rine, although the other cardiohemodynamic pa-
rameters responded in a way similar to those of the
other 12 dogs. Close inspection of the change in
reservoir volume revealed that the volume de-
creased initially in four of the 12 dogs.
Effects of Methoxamine
Methoxamine was infused at rates of 10, 30, and
100 jug/kg per min for 3 minutes into the ascending
aorta in six dogs. Data are summarized in Figure 5.
The pattern of response of the systemic blood pres-
sure to methoxamine was similar to that for nor-
epinephrine. However, unlike norepinephrine,
methoxamine decreased the reservoir volume and
increased the right atrial pressure. The heart rate
was not affected by methoxamine.
Series 2: The Effects of Isoproterenol before
and after Bilateral Carotid Sinus
Denervation
To determine to what extent the baroceptor re-
flex triggered by isoproterenol-induced hypotension
might be involved in the cardiohemodynamic ef-
fects of isoproterenol, the effects of isoproterenol
were studied before and after bilateral carotid sinus
denervation in five vagotomized dogs. Since both
vagi had been severed, carotid sinus denervation
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FIGURE 2 Cardiohemodynamic ef-
fects of isoproterenol infused into the
right atrium or into the ascending
aorta. Periods of infusion (3 minutes)
are indicated by horizontal solid lines,
under which infusion rates are given.
Abbreviations except for MtV are the
same as in Figure 1. Ai? V is a change
in volume of the second reservoir.
was sufficient to eliminate the baroceptor reflex.
After carotid sinus denervation, the mean systemic
blood pressure increased by 24 ± 10 mm Hg and
the heart rate by 12 ± 4 beats/min. However,
changes in cardiohemodynamic parameters in re-
sponse to isoproterenol were not different before
and after this intervention (P > 0.3).
Series 3: Modification of the Effects of
Isoproterenol and Norepinephrine by
Propranolol
The effects of norepinephrine on cardiohemody-
namics were determined in five vagotomized dogs
before and after propranolol in doses which just
FIGURE 3 Dose-response curves for cardiohemody-
namic parameters to isoproterenol infused at rates of
0.03, 0.1, and 0.3 fig/kg per min for 3 minutes into the
ascending aorta (left panel) or into the right atrium
(right panel). O = Change in systolic blood pressure
(n = 10-11); • = change in diastolic blood pressure
(n = 10-11); O = change in reservoir volume (n = 10-11);
• = change in right atrial pressure (n = 5); A = change
in heart rate (n = 10-11). Each symbol represents the
mean ± SE. * P < 0.05, ** P < 0.01, and *** P < 0.001
compared to values obtained when corresponding doses
were infused into the ascending aorta.
abolished the effects of isoproterenol (0.1 j^g/kg per
min for 3 minutes). After a single dose of propran-
olol, 0.3 mg/kg, systolic blood pressure remained
almost unchanged, but diastolic blood pressure in-
creased by 8 ± 1 mm Hg and right atrial pressure
by 16 ± 6 mm H2O. With this dose, the reservoir
volume decreased by 5.9 ± 1.2 ml/kg and heart rate
by 26 ± 6 beats/min. Figure 6 shows results of one
of such experiments. Of the changes produced by
propranolol, 0.3 mg/kg, the decrease in reservoir
volume was most marked and of such a long dura-
03 1 3
DOSE (;jg/kg/min)
FIGURE 4 Dose-response curves for cardiohemody-
namic parameters to norepinephrine infused at rates of
0.3, 1, and 3 ftg/kg per min for 3 minutes into the
ascending aorta. O = Change in systolic blood pressure
(n = 12-13); • = change in diastolic blood pressure (n
= 12-13); €> = change in reservoir volume (n = 12-13);
D = change in right atrial pressure (n = 8-10); A =
change in heart rate (n = 12-13). Otherwise, the same as
in Figure 3.
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FIGURE 5 Dose-response curves for cardiohemody-
namic parameters to methoxamine infused at rates of
10, 30, and 100 fig/kg per min for 3 minutes into the
ascending aorta. O = Change in systolic blood pressure
(n = 6); • = change in diastolic blood pressure (n = 6);
O = change in reservoir volume (n = 6); • = change in
right atrial pressure (n = 5); • = change in heart rate
(n = 5-6). Otherwise, the same as in Figure 3.
tion that the volume hardly began to return toward
the initial volume. For complete abolition of the
cardiohemodynamic effects of isoproterenol, 0.1
fig/kg per min for 3 minutes, three successive injec-
tions of propranolol, 0.3 mg/kg, were needed. Since
after such treatment the reservoir volume remained
decreased and was off scale on the charts, the zero
line was shifted as shown by an arrow in Figure 6.
After yS-adrenergic receptor blockade had been con-
firmed, as above, norepinephrine was infused into
the ascending aorta at a rate of 3 /ng/kg per min for
3 minutes. Rather than increasing reservoir volume,
norepinephrine induced a decrease, and right atrial
pressure was increased. The changes resembled
those produced by methoxamine, except that nor-
epinephrine increased heart rate. Figure 7 summa-
rizes the results obtained with norepinephrine (1
/tg/kg per min for 3 minutes) before and after pro-
pranolol. In this figure, increases in systolic and
diastolic blood pressure and heart rate induced by
norepinephrine appear to be greater after propran-
olol, but these changes were not statistically sig-
nificant (P > 0.1). Only the changes in reservoir
volume caused by norepinephrine were significantly
different before and after propranolol (P < 0.05).
Series 4: Modification of the Effects of
Methoxamine by a Vasodilator Drug, SK&F
24260
Five vagotomized dogs were examined to see
whether the cardiohemodynamic effects of meth-
oxamine were different when vascular tone was
reduced by vasodilator drugs. For this purpose,
SK&F 24260 was chosen because it is a long-acting
and potent hypotensive drug10 having rather little
cardiodepressant action.1112 In the five dogs that
received a single injection of SK&F 24260 (30
jug/kg), the systolic and diastolic blood pressures
clearly were lower than those of untreated dogs
(series 1 experiments), 74 ± 9 and 33 ± 6 mm Hg as
against 133 ± 12 and 63 ± 9 mm Hg in the untreated
dogs. After SK&F 24260, the reservoir volume
tended to decrease for a long period after the initial
increase. In the dogs given SK&F 24260, methoxa-
mine (100 jug/kg per min for 3 minutes) increased
venous return, although other changes were not
significantly different from those obtained from the
untreated dogs (P > 0.05) (Fig. 8). The increase in
reservoir volume is in contrast to the decrease ob-
tained in the untreated dogs (P < 0.01).
Series 5: Effects of Three Sympathomimetic
Amines on the Systemic Output and Total
Peripheral Resistance
To determine whether the three sympathomi-
metic amines might affect the systemic output and
whether the change in systemic output, if any,
caused by these drugs might result in change in
venous return, the effects on systemic output were
200
SBP
mmHg 100
0
RAP
mmH20
HR 200r
beats/minioo'-
ISOPROTERENOL
Oijjg/kg/nmn NOREPINEPHRINE PR0PRANOUX PROP P'ROP ISO NOR
3
"
1
"
1
3j jg/kg/min 03mg/kg 0-3 03 01 3jjg/kg/min
mg/kg mg/kg jjg/kg/min
FIGURE 6 Cardiohemodynamic ef-
fects of isoproterenol (0.1 ng/kg per
min for 3 minutes) and norepineph-
rine (3 fig/kg per min for 3 minutes)
and their modification by propran-
olol (0.9 mg/kg). The zero base line
reference is reset at an arrow. Ab-
breviations are the same as in Fig-
ure 1.
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d R A P
FIGURE 7 Effects ofpropranolol (0.9 mg/kg) on changes
in cardiohemodynamic parameters in response to nor-
epinephrine (1 fig/kg per min for 3 minutes). Each bar
represents the mean ± SE (n = 5). Unfilled bars refer to
controls and hatched bars refer to the results after
propranolol. Changes in cardiohemodynamic param-
eters except for Aft Vin response to norepinephrine after
propranolol were not significantly different from respec-
tive controls (P > 0.05).
studied in eight dogs. Blood flow through the de-
scending thoracic aorta and the brachiocephalic
artery was measured individually by the use of two
cannulating flow probes, after the left subclavian
artery had been ligated. The systemic output for 3
minutes was determined in the following way. The
blood volume passing for 3 minutes through each of
these two vessels was measured planimetrically
from blood flow tracings on the chart. The blood
volume thus obtained was summed and divided by
the body weight of the animal. This yielded the
systemic output for 3 minutes in terms of liters/kg.
Such measurements were made for 3 minutes just
before and during infusion of the three sympatho-
mimetic amines to obtain control values and those
during drug action. The systemic output used for
20 40 60<m m H9>
AS BP
ADBP
AR V
AH R
Z l R A P
-2 -A -6 (ml/kg)
p<001
1 3 (beats/min)
6 (mmH;0)
FIGURE 8 Effects of the vasodilator drug, SK&F 24260
(30 ng/kg), on changes in cardiohemodynamic param-
eters caused by methoxamine (100 (ig/kg per min for 3
minutes). Unfilled bars refer to controls taken from
series 1 experiments (n = 5-6). Hatched bars refer to
results obtained from dogs treated with SK&F 24260
(n = 5). Otherwise, the same as in Figure 7.
calculation of total peripheral resistance (TPR) was
obtained by dividing the values determined as
above by 3 minutes. TPR was calculated as follows:
TPR = mean systemic blood pressure/systemic
output (mm Hg min/liter). Isoproterenol (0.3 jug/kg
per min), norepinephrine (1 fig/kg per min), and
methoxamine (100 jug/kg per min) were infused for
3 minutes into the ascending aorta. These three
sympathomimetic amines produced almost the
same cardiohemodynamic changes as they did in
series 1 experiments. With infusion of these three
sympathomimetic amines, the systemic output re-
mained virtually unchanged (Table 2). The total
peripheral resistance was definitely decreased by
isoproterenol (P < 0.05), whereas it was increased
by norepinephrine (P < 0.05) and methoxamine (P
< 0.05) (Table 3).
Discussion
In the present experiments which used the open-
loop method, infusion of isoproterenol into the as-
cending aorta increased venous return, i.e., blood
volume of the reservoir from which blood was
pumped at a constant rate into the cannulated right
atrium. The present results are consistent with
those obtained by Kaiser et al.6 in dogs on cardio-
pulmonary bypass and by Green8 in dogs on right
heart bypass with intravenous infusion of isoprote-
renol. Several possible causes of the increased ve-
nous return induced by isoproterenol can be consid-
ered: (1) an increase in systemic output in spite of
the controlled cardiac input, (2) "squeezing out" of
blood from the systemic venous bed by reflex ven-
oconstriction triggered by hypotension in response
to isoproterenol, (3) "squeezing out" of blood from
the systemic venous bed by venoconstriction in its
direct response to isoproterenol, (4) translocation of
blood from the arterial to the venous side and
finally to the blood reservoir owing to a decrease in
resistance of the peripheral arterial bed, and (5)
shift of blood from the capillary and venous beds to
the blood reservoir owing to a decrease in venous
resistance.
The first possibility arises from the finding that
isoproterenol increased the heart rate to some ex-
tent although it was infused into the ascending
aorta to minimize the cardiac effect. The increase
in heart rate reflects a stimulant action on the
TABLE 2 Effects of Three Sympathomimetic Amines
on Systemic Output
Drug
Isoproterenol
Norepinephrine
Methoxamine
Dose
Oig/kg per
min for
3 min)
0.3
1
100
No. of
dogs
5
5
5
Systemic output
(ml/kg for 3 min)
Before
infusion
209 + 14
192 ± 20
188 ±22
After
infusion
211 ± 14'
193 ± 20*
187 ± 23*
Values are means ± SE.
* P > 0.05 compared to "Before infusion."
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TABLE 3 Effects of Three Sympathomimetic Amines on
Total Peripheral Resistance
Drug
Isoproterenol
Norepinephrine
Methoxamine
Dose
(^g/kg per
min for
3 min)
0.3
1
100
No. of
dogs
5
5
5
Total peripheral
resistance
(mm Hg • min/liter)
At 3 min
Before after
infusion infusion
116 ±19 89 ± 12*
112 ± 23 157 ± 16*
107 ± 11 171 ± 19*
* P < 0.05 compared to "Before infusion."
heart. This cardiostimulant effect might cause an
increase in the systemic output by mobilization of
blood from capacitance in the heart and lung vas-
culature despite the controlled cardiac input. How-
ever, the possibility appears to be ruled out by the
finding obtained in series 5 experiments in which
the systemic output was measured with the flow
probe. In these experiments, the systemic output
was not changed during infusion of isoproterenol
into the ascending aorta. However, doubt still re-
mains as to whether the flowmeters used to measure
the systemic output of the order of about 0.6
liter/min might not detect a change in blood flow
as small as 20 ml for 3 minutes. Nevertheless, the
circumstantial evidence obtained from series 1 ex-
periments can rule out the possibility that the in-
creased venous return caused by isoproterenol
might result from the increased systemic output. In
series 1 experiments, the increase in reservoir vol-
ume caused by infusion of isoproterenol into the
ascending aorta was not significantly different from
that obtained with infusion of isoproterenol into the
right atrium, although the increase in heart rate
was more marked in the latter case. The cardiostim-
ulant action of isoproterenol should be more
marked when it is administered into the right
atrium than when it is given into the ascending
aorta. This finding is enough to rule out a possible
increase in cardiac output induced by the cardio-
stimulant action of isoproterenol which might lead
to an increased venous return.
The second possibility, that the increased venous
return might be due to reflex venoconstriction re-
sulting from hypotension, can be ruled out by the
results of the series 2 experiments. Elimination of
the baroceptor reflex of sinoaortic origin failed to
modify the increased venous return induced by
infusion of isoproterenol into the ascending aorta.
The third possibility, that the increased venous
return might be due to venoconstriction as a direct
response of the systemic venous bed, has been
suggested by Kaiser et al.6 Here an action of adre-
nergic receptors involved in venomotion should be
inferred. Available data13 indicate that veins have
both a- and /?-adrenergic receptors. Kaiser et al.6
speculated that venoconstriction responsible for the
increased venous return might be mediated through
/?-adrenergic receptors. However, in vivo experi-
ments on the cutaneous veins of the dog14 and on
various venous beds15"19 have demonstrated that
isoproterenol causes venodilation by stimulation of
/?-adrenergic receptors. In vitro experiments on iso-
lated veins have also shown that isoproterenol
causes relaxation when the veins have some initial
tone.1318 Thus, it is difficult to assume that the
increased venous return caused by isoproterenol is
due to venoconstriction mediated through /?-adre-
nergic receptors. It is also known that isoproterenol
in large doses causes constriction of isolated veins
by stimulating a-adrenergic receptors.13 Thus, it is
possible that the increased venous return induced
by isoproterenol might result from venoconstriction
mediated through a-adrenergic receptors. However,
this possibility can be ruled out by the following
findings obtained in the present experiments: (1)
isoproterenol in low doses produced a dose-depend-
ent increase in venous return (series 1 experiments);
(2) the increased venous return induced by isopro-
terenol was abolished almost completely by the /?-
receptor blocking dose of propranolol (series 3 ex-
periments); (3) the a-adrenergic stimulant, meth-
oxamine, as well as norepinephrine in the presence
of y8-adrenergic receptor blockade (propranolol),
caused a decrease in venous return when vascular
tone was maintained (series 1 and 3 experiments).
Guimaraes and Osswald18 have also demonstrated
that isoproterenol never stimulates a-adrenergic re-
ceptors to cause constriction of several autoper-
fused veins in the dog.
The fourth possibility is that the decrease in
arterial resistance might result in translocation of
blood from the arterial to the venous side and
finally to the extracorporeal reservoir. This possi-
bility has been proposed by Emerson20'21 to inter-
pret the increased venous return induced by vaso-
dilator agents like bradykinin and prostaglandin Ei.
As the results from series 5 experiments clearly
indicate, total peripheral resistance was definitely
decreased by infusion of isoproterenol into the as-
cending aorta. However, norepinephrine also in-
creased venous return although it increased total
peripheral resistance. Thus, a change in venous
return cannot be interpreted as being induced by a
change in arterial resistance.
The fifth possibility appears the most plausible,
i.e., that an increase in venous return caused by
isoproterenol may be a result of decreased venous
resistance. Guyton et al.22 calculated that a given
change in venous resistance affects venous return
about 8 times as much as the same change in
arterial resistance. Although in the conceptual
framework of Guyton et al.22 it is unclear what
venous segments mainly behave as venous resist-
ance, venous sphincters may be responsible. For
example, such sphincters in the hepatic vein are
thought to control the blood volume in the splanch-
nic bed.8'23 Stimulation of /?-adrenergic receptors
by isoproterenol may dilate such sphincters to cause
a shift of blood from the systemic venous bed to the
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extracorporeal reservoir. Green8 has suggested that
the hepatic sphincter would play an important role
in the increased venous return induced by isopro-
terenol. The decrease in venous resistance also may
lead to the increased venous return by translocation
of blood from the capillary to the venous side and
by a shift of the body fluid from the extravascular
to the vascular space due to the decreased capillary
hydrostatic pressure.24
Infusion of the a-adrenergic stimulant, methoxa-
mine, into the ascending aorta decreased venous
return. Veins contract through stimulation of a-
adrenergic receptors.13'18'25 Thus, it can be expected
that methoxamine causes venoconstriction (a de-
crease in venous capacitance) and leads to the
increased venous return. However, a decrease in
capacitance of veins needs not be associated with
an increase in venous return at constant right atrial
pressure.26 Moreover, the observed change in ve-
nous return was opposite to that which is expected.
Therefore, the decrease in venous return should be
ascribed to elevation of venous resistance. The de-
crease in venous return in response to methoxa-
mine, however, presupposes the presence of vascu-
lar tone. In dogs in which vascular tone was greatly
reduced by the vasodilator drug, SK&F 24260,
methoxamine increased venous return (series 4 ex-
periments). This can be interpreted as being due to
a decrease in vascular capacitance. A decrease in
the systemic output may also account for a part of
the decreased venous return. Although there was
no statistically significant difference between the
control systemic output and that measured during
the 3-minute infusion of methoxamine, an overt
increase in right atrial pressure in response to
higher doses of methoxamine indicates pooling of
blood in the heart and lung vasculature due to the
increased afterload on the heart, and suggests a
decreased systemic output.
Norepinephrine, like isoproterenol, increased ve-
nous return although, unlike isoproterenol, it in-
creased total peripheral resistance (series 5 experi-
ments). Since the change in arterial resistance did
not result in a change in venous return, as discussed
in the preceding paragraph, an increase in venous
return caused by norepinephrine is by no means
attributable to an event on the arterial side, but
rather to one on the venous side. Norepinephrine
stimulates both a- and /J-adrenergic receptors. In
the presence of norepinephrine, sphincters in veins
and venous beds would tend to contract through
stimulation of a-adrenergic receptors there. How-
ever, if venous sphincters are more sensitive to /?-
than to a-adrenergic stimulation, as compared with
venous beds, sphincters would relax whereas venous
beds would remain contracted in the presence of
norepinephrine. In other words, with norepineph-
rine, venous resistance and capacitance would be
decreased, favoring an increase in venous return. If
/8-adrenergic receptors were blocked, the situation
would be reversed; a decrease in venous return by
propranolol was found (series 3 experiments).
In conclusion, three sympathomimetic amines,
when infused into the ascending aorta, changed
venous return, probably by the following mecha-
nisms: (1) isoproterenol increased venous return
mainly by a decrease in venous resistance through
stimulation of /8-adrenergic receptors; (2) methox-
amine, an a-adrenergic stimulant, decreased venous
return mainly by increasing venous resistance
through stimulation of a-adrenergic receptors, al-
though it may have acted to increase venous return
through a decrease in venous capacitance; (3) nor-
epinephrine, which has stimulant actions on both
a- and /?-adrenergic receptors, increased venous
return probably by reduction of venous resistance
and capacitance; /?-adrenergic receptors are mainly
responsible for the former change and a-adrenergic
receptors for the latter.
Addendum
Just after submission of the manuscript, a perti-
nent paper by Green appeared (JF Green: Mecha-
nism of action of isoproterenol on venous return.
Am J Physiol 232: H152-156, 1977). In that paper,
Green demonstrated that isoproterenol increases
venous return mainly by dilating the hepatic
sphincter through a /?-adrenergic mechanism.
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Effects of Hypertension and Its Reversal on
Aortic Metabolism in the Rat
PETER BRECHER, CATHERINE T. CHAN, CARL FRANZBLAU, BARBARA FARIS,
AND ARAM V. CHOBANIAN
SUMMARY The relationship between aortic metabolism and hypertension was examined in sponta-
neously hypertensive rats (SHR) and in the normotensive Wistar-Kyoto (WKY) strain of rats. Compar-
ative studies between age-matched animals of both strains showed in the SHR, enhanced activities of
the aortic enzymes, iV-acetyl /9-glucosaminidase (NAGA) and acid phosphatase, which are associated
with lysosomes. Similar increases were shown for aortic 5 -nucleotidase activity. Antihypertensive
drug treatment of 30-week-old SHR for 17 weeks effectively lowered blood pressure and reduced the
activity of aortic NAGA and acid phosphatase in the SHR to control levels. 5'-Nucleotidase activity
remained significantly elevated, and aortic collagen and elastin concentrations were unaffected by
antihypertensive drug treatment. Hypertension was produced in WKY rats by deoxycorticosterone
treatment for either 4 or 7 weeks and then was reversed by discontinuing treatment and maintaining
the pretreated animals on a low-salt diet for up to 11 weeks. At the end of the treatment period, aortic
enzymatic activity was increased significantly, as were heart and aortic weights. Following the reversal
of hypertension, the activity of the lysosomal enzymes was decreased significantly, but 5-nucleotidase
activity remained elevated. Collagen and elastin concentrations were not affected by mineralocorticoid
treatment, but the total amount of connective tissue protein was increased and remained elevated
following the reversal of hypertension, paralleling the changes in aortic weight. The studies indicate
that etiologically different forms of hypertension result in characteristic changes in aortic metabolism
which are not completely reversed by subsequent blood pressure reduction.
HYPERTENSION is known to be an important
risk factor for atherosclerosis in man, but the bio-
chemical basis for this relationship has not yet been
established. Changes in the vascular endothelium
of hypertensive animals may lead to increased vas-
cular permeability and smooth muscle cell prolif-
eration, thereby contributing to the development of
atherosclerotic lesions.1"3 Wolinsky et al.4 have
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